Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Medpace is a full-service clinical research organization (CRO) that provides integrated drug development services, including central laboratories, bioanalytical labs, imaging, and cardiac safety. The company uses a single-vendor model to streamline complex clinical trials, embedding cross-functional expertise from early planning through closeout to ensure quality and efficiency.
Parse Score
Where AI is strongest on it
Decentralized trial platform
Emerging but stronger AI signal: Medpace is recommended for DCT features including eConsent/ePRO plus home health and telehealth integration.
Where it hedges or trails
Rare disease patient recruitment
AI recommends Medpace for rare disease recruitment (planning, site identification, patient support) but the signal is weaker compared with DCT feature recommendations.
Parse Score